#Italy #Milan #Kyowa Hakko Bio #Citicoline #EMEA Gateway

Kyowa Hakko Bio Italia's New Chapter: Leading EMEA's Health Science Growth

Kyowa Hakko Bio Co., Ltd. has recently announced a significant transformation by integrating its former German affiliate into its operations, establishing Kyowa Hakko Bio Italia (KHIT) as a central commercial hub for the broader Europe, Middle East, and Africa (EMEA) region. This strategic move aims to sharpen the company’s focus on advancing its Health Science growth strategy, particularly emphasizing the Cognizin® Citicoline segment.

A Stronger Regional Presence

The integration of the German affiliate marks a pivotal milestone in Kyowa Hakko's journey, solidifying its operations and enhancing its capacity to serve diverse markets across EMEA. By unifying its commercial efforts under KHIT, Kyowa Hakko Bio is poised to create a distinct regional framework that not only elevates its operational efficiency but also enhances the scientific value delivered to its customers.

Cognizin® Citicoline plays a vital role in Kyowa Hakko Bio's strategy, particularly within health science and dietary supplement sectors. As these markets evolve, KHIT is committed to leveraging its innovative capabilities to provide science-backed solutions that contribute to health and well-being across the region.

Leadership to Drive Change

Effective from October 1, 2025, Mr. Nicola Urso has been appointed the President of KHIT. With nearly 25 years of experience within Kyowa Hakko, Mr. Urso has a proven track record of navigating the complexities of the biotech landscape. Under his leadership, KHIT aims to implement an expedited and agile operating model that allows for more rapid decision-making and deeper customer engagement.

Mr. Urso encapsulates the vision, stating, “This evolution marks a new chapter in our European journey. With a more agile structure and a clear regional remit, KHIT is poised to deliver greater scientific value to customers across EMEA, faster and more effectively than ever before.”

Introducing a Scientific Marketing Focus

In line with this transformation, KHIT intends to roll out a dedicated Scientific Marketing Function led by Dr. Eri Nakazaki. This team will focus on converting scientific insights into robust marketing narratives, allowing Kyowa Hakko to position itself as a leader in health science.

By fostering strong collaborations with global research and development teams, KHIT will ensure that cutting-edge scientific research translates into effective marketing strategies and customer programs, enhancing market presence across the region.

Mission and Vision of KHIT

The mission of Kyowa Hakko Bio Italia emphasizes delivering high-quality, science-backed ingredients focused on improving health and well-being throughout EMEA. The vision includes establishing KHIT as Kyowa’s recognized gateway into Europe, esteemed for scientific excellence and sustainable growth within the health science and dietary supplement domains.

What’s New with KHIT?

Unified EMEA Gateway

• - KHIT will serve as Kyowa's sole commercial platform for EMEA, featuring local GMP stock approved by health authorities, thus facilitating faster market execution.

Enhanced Health Science Focus

• - There will be a concentrated push on the Cognizin® portfolio and adjacent market opportunities, aimed clearly at augmenting growth in the health sciences sector.

Advanced Science Marketing Capability

• - A dedicated team will craft compelling narratives based on scientific evidence, positioning Kyowa Hakko Bio as a thought leader in its markets.

Partnerships to Drive Innovation

• - KHIT plans to enhance its collaboration with global food and nutrition leaders to support innovation and long-term growth of health solutions.

As Mr. Urso concludes, “By combining world-class science with sharper execution, Kyowa Hakko Bio Italia is set to elevate Kyowa's presence and performance across EMEA. We're committed to turning differentiated science into long-term value for our customers.”

About Kyowa Hakko Bio Italia

Kyowa Hakko Bio Italia S.R.L. is recognized as the EMEA commercial hub of Kyowa Hakko Bio Co., Ltd., known for over 75 years of biotech innovation. It provides premium, scientifically substantiated ingredients for the nutraceutical, pharmaceutical, functional food, and wellness industries, including well-established brands like Cognizin® Citicoline and Setria® Glutathione. With a steadfast commitment to quality and collaboration, Kyowa Hakko Bio Italia is dedicated to developing transformative health solutions that enhance well-being and deliver shared value across its partners.